# Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines

> **NCT01651247** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Presence of Materials From PCV-1

## Interventions

- **PROCEDURE:** Serum sample

## Key facts

- **NCT ID:** NCT01651247
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2012-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651247, "Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01651247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*